131 filings
Page 5 of 7
S-8
8l9tgo
16 Jul 21
Registration of securities for employees
4:31pm
6-K
ujtd622
13 May 21
PAINREFORM LTD. Condensed UNAUDITED FINANCIAL STATEMENTS
9:18am
EFFECT
no2jg2 4eb1w83r
12 Apr 21
Notice of effectiveness
12:15am
424B3
q1c8r6ommxbr 7phl9m
9 Apr 21
Prospectus supplement
4:36pm
CORRESP
o8xxyaj3 fnfsh9vko
8 Apr 21
Correspondence with SEC
12:00am
UPLOAD
ri47 h47re
6 Apr 21
Letter from SEC
12:00am
F-1
n706 jq6v
1 Apr 21
Registration statement (foreign)
5:29pm
EFFECT
gtqipelvjv3btd
24 Mar 21
Notice of effectiveness
12:15am
POS AM
1ncjg xe36yv
22 Mar 21
Prospectus update (post-effective amendment)
4:15pm
D
zls5va1clzqwxblfpz
19 Mar 21
$6M in equity / options / securities to be acquired, sold $6M, 3 investors
4:15pm
6-K
kl8odtwm1h5loq
18 Mar 21
PainReform Provides Year-End Business Update and Reports Progress Towards
10:36am
20-F
xj0tznboiodwrt46k
18 Mar 21
Annual report (foreign)
9:03am
6-K
t34nd0o
9 Mar 21
PainReform Announces $6.0 Million Private Placement
4:15pm
6-K
r1jomfe
1 Mar 21
Report of Foreign Private Issuer
7:00am
6-K
vzgwj
23 Feb 21
Report of Foreign Private Issuer
4:30pm
6-K
fj0ggz8tv3ykiimras
19 Jan 21
Extraordinary General Meeting of Shareholders
4:35pm
6-K
dm8 kpfut1
6 Jan 21
PainReform Appoints Rita Keynan as Vice President of Pharmaceutical Operations
9:00am
6-K
o8pit
5 Jan 21
Investor Presentation January 2021
4:15pm
6-K
yqb454zhryxshe
4 Jan 21
PainReform Announces Appointment of Lotus Clinical Research as CRO for Phase 3 Clinical Trial of PRF-110
4:16pm
424B3
8z8x0
25 Nov 20
Prospectus supplement
11:12am